Gain Therapeutics Ownership | Who Owns Gain Therapeutics?

Gain Therapeutics Ownership Summary

Gain Therapeutics is owned by 2.58% institutional investors, 5.01% insiders, and 92.41% retail investors. Dme capital management, lp is the largest institutional shareholder, holding 2.13% of GANX shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.64% of its assets in Gain Therapeutics shares.

GANX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Gain Therapeutics	2.58%	5.01%	92.41%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Dme capital management, lp	566.13K	2.13%	$1.22M
Hohimer wealth management	330.00K	1.84%	$422.40K
Geode capital management	267.42K	1.01%	$577.70K
Vanguard group	177.07K	0.67%	$382.48K
Gotham asset management	158.16K	0.60%	$3.74M
Blackrock	84.62K	0.47%	$108.31K
Jones financial companies lllp	98.25K	0.37%	$212.22K
Marshall wace, llp	91.74K	0.35%	$198.16K
Blackrock funding, inc. /de	86.06K	0.32%	$185.89K
State street	71.14K	0.27%	$153.66K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Hohimer wealth management	330.00K	0.10%	$422.40K
Dme capital management, lp	566.13K	0.06%	$1.22M
Gotham asset management	158.16K	0.04%	$3.74M
Benedict financial advisors	16.00K	0.01%	$34.56K
Prelude capital management	35.82K	0.00%	$77.37K
Sandhill capital partners	15.40K	0.00%	$33.26K
Virtu financial	27.36K	0.00%	$35.00K
Creekmur asset management	4.44K	0.00%	$9.59K
Sprott	14.00K	0.00%	$30.24K
Bridgeway capital management	30.00K	0.00%	$64.81K

Top Buyers

Holder	Shares	% Assets	Change
Hohimer wealth management	330.00K	0.10%	330.00K
Marshall wace, llp	91.74K	0.00%	91.74K
Cambridge investment research advisors	54.50K	0.00%	54.50K
Susquehanna group, llp	46.91K	-	46.91K
Jones financial companies lllp	98.25K	0.00%	44.75K

Top Sellers

Holder	Shares	% Assets	Change
Timelo investment management	-	-	-605.29K
Alyeska investment group	-	-	-450.00K
Raymond james & associates	-	-	-260.02K
Gotham asset management	158.16K	0.04%	-176.44K
Cable car capital	-	-	-145.00K

New Positions

Holder	Shares	% Assets	Change	Value
Hohimer wealth management	330.00K	0.10%	330.00K	$422.40K
Marshall wace, llp	91.74K	0.00%	91.74K	$198.16K
Cambridge investment research advisors	54.50K	0.00%	54.50K	$118.00K
Susquehanna group, llp	46.91K	-	46.91K	$101.33K
Virtu financial	27.36K	0.00%	27.36K	$35.00K

Sold Out

Holder	Change
Newedge advisors	-225.00
Hm payson	-1.00K
Group one trading	-1.40K
Citadel advisors	-2.50K
Simplex trading	-4.80K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	10	-50.00%	683,297	-59.21%	2	6.46%	6	-33.33%	1	-75.00%
Sep 30, 2024	20	-25.93%	1,675,173	-44.84%	6	2.21%	9	-50.00%	4	-20.00%
Jun 30, 2024	27	-10.00%	3,036,722	62.60%	16	12.72%	18	20.00%	5	-28.57%
Mar 31, 2024	30	15.38%	1,867,615	20.86%	11	7.79%	15	36.36%	7	16.67%
Dec 31, 2023	26	-	1,545,247	1.96%	12	8.13%	11	-8.33%	6	20.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Institutional Extnd Mkt Idx Tr	169.80K	0.64%	1.01K
Fidelity Extended Market Index	138.44K	0.50%	-882.00
BANOR SICAV Rosemary S EUR Acc	50.00K	0.18%	-
Fidelity Total Market Index	45.18K	0.16%	-
BlackRock Extended Equity Market K	36.53K	0.14%	-16.00
iShares Micro-Cap ETF	38.52K	0.14%	-
Extended Equity Market Fund K	36.15K	0.13%	111.00
Fidelity Series Total Market Index	33.44K	0.12%	-
Bridgeway Ultra-Small Company Market	30.00K	0.11%	30.00K
Northern Trust Extended Eq Market Idx	29.48K	0.11%	13.86K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 09, 2024	Mack Gene	CFO and Interim CEO	Buy	$14.54K
Aug 09, 2024	Islam Khalid	Executive Chairman	Buy	$49.94K
Jul 01, 2024	RICHMAN ERIC I	-	Buy	$14.52K
Jul 01, 2024	RICHMAN ERIC I	-	Buy	$6.15K
Mar 28, 2024	Riley Jeffrey Scott	-	Buy	$115.77K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q3	4	-
2024 Q2	-	-
2024 Q1	1	-
2023 Q4	-	2

GANX Ownership FAQ

Who Owns Gain Therapeutics?

Gain Therapeutics shareholders are primarily institutional investors at 2.58%, followed by 5.01% insiders and 92.41% retail investors. The average institutional ownership in Gain Therapeutics's industry, Biotech Stocks , is 68.48%, which Gain Therapeutics falls below.

Who owns the most shares of Gain Therapeutics?

Gain Therapeutics’s largest shareholders are Dme capital management, lp (566.13K shares, 2.13%), Hohimer wealth management (330K shares, 1.84%), and Geode capital management (267.42K shares, 1.01%). Together, they hold 4.98% of Gain Therapeutics’s total shares outstanding.

Does Blackrock own Gain Therapeutics?

Yes, BlackRock owns 0.47% of Gain Therapeutics, totaling 84.62K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 108.31K$. In the last quarter, BlackRock increased its holdings by 9.22K shares, a 12.23% change.

Who is Gain Therapeutics’s biggest shareholder by percentage of total assets invested?

Hohimer wealth management is Gain Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.10% of its assets in 330K Gain Therapeutics shares, valued at 422.4K$.

Who is the top mutual fund holder of Gain Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Gain Therapeutics shares, with 0.64% of its total shares outstanding invested in 169.8K Gain Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools